Glucose degradation products: relationship with cell damage
Witowski, J.; Jörres, A.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 20(Suppl 2): S31-S36
2000
ISSN/ISBN: 0896-8608 PMID: 10911640 Document Number: 519102
Document emailed within 1 workday
Related Documents
Lin, X.; Amore, A.; Loiacono, E.; Balegno, S.; Manniello, D.; Peruzzi, L.; Camilla, R.; Minieri, V.; Daprà, V.; Qian, J.; Coppo, R. 2009: Effect of glucose degradation products, glucose-containing dialysate and icodextrin on AQP1 and eNOS expression in cultured endothelial cells Journal of Nephrology 22(1): 117-122Jörres, A.; Bender, T.O.; Witowski, J. 2000: Glucose degradation products and the peritoneal mesothelium Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(Suppl 5): S19-S22
Witowski, J.; Bender, T.O.; Gahl, G.M.; Frei, U.; Jörres, A. 2001: Glucose degradation products and peritoneal membrane function Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(2): 201-205
Wieslander, A.; Forsbäck, G.; Svensson, E.; Lindén, T. 1996: Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 12: 57-60
Wieslander, A.; Linden, T.; Kjellstrand, P. 2001: Glucose degradation products in peritoneal dialysis fluids: how they can be avoided Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(Suppl 3): S119-S124
Diaz-Buxo, J.A. 2007: Peritoneal dialysis solutions low in glucose degradation products: clinical experience and outcomes Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 23: 132-134
Wieczorowska-Tobis, K.; Brelinska, R.; Witowski, J.; Passlick-Deetjen, J.; Schaub, T.P.; Schilling, H.; Breborowicz, A. 2004: Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 24(1): 48-57
Xue, Z.M. 1981: The relationship between the estimation of fibrin fibrinogen degradation products and euglobulinolytic test and its clinical significance Zhonghua Nei Ke Za Zhi 20(2): 92-94
Vlodavsky, I.; Fuks, Z.; Bar-Ner, M.; Ariav, Y.; Schirrmacher, V. 1983: Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis Cancer Research 43(6): 2704-2711
Wojtecka-Lukasik, E.; Maśliński, S. 1992: Fibronectin and fibrinogen degradation products stimulate PMN-leukocyte and mast cell degranulation Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 43(2): 173-181
Bachvaroff, R.J.; Ayvazian, J.H.; Skupp, S.; Rapaport, F.T. 1977: Specific restriction endonuclease degradation of DNA as a consequence of immunologically mediated cell damage Transplantation Proceedings 9(1): 807-812
Vakhidova, G.A.; Kul'berg, A.I. 1989: Degradation products of cell receptors and natural antibodies in patients with various forms of pulmonary tuberculosis Problemy Tuberkuleza 60(8): 50-53
Li, W.-M.; Bao, Y.-Y.; Zhou, Q.-X. 2012: Degradation pathways and main degradation products of tetracycline antibiotics: research progress Ying Yong Sheng Tai Xue Bao 23(8): 2300-2308
Fornaini, G.; Bossù, M.; Fazi, A.; Piatti, E.; Ninfali, P.; Palma, F.; Piacentini, M.P.; Accorsi, A. 1986: The relevance of glucose 1,6-bisphosphate formation and degradation to human red blood cell metabolism Italian Journal of Biochemistry 35(5): 310-315
Nabeshima, K.; Kataoka, H.; Koono, M. 1986: Enhanced migration of tumor cells in response to collagen degradation products and tumor cell collagenolytic activity Invasion and Metastasis 6(5): 270-286
Bian, H.; Gao, X.; Gao, J. 2009: Relationship between glucose fluctuation and beta cell function in patients with diabetes Zhonghua Yi Xue Za Zhi 89(10): 664-668
Koomägi, R.; Mattern, J.; Volm, M. 1999: Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas Anticancer Research 19(5b): 4333-4336
Kuroso, K.; Fujimaki, M. 1989: Fibrin/fibrinogen degradation products (FDP) Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 892-895
Fujimaki, M.; Ikematsu, S.; Kato, M. 1973: Fibrinogen and fibrin degradation products Rinsho Byori. Japanese Journal of Clinical Pathology 21(1): 31-36
Tada, H.; Kuboki, K.; Isogai, S. 1998: Urinary fibronectin degradation products Nihon Rinsho. Japanese Journal of Clinical Medicine 56(Suppl 3): 354-359